Price Chart

Executive Summary

Synlogic (SYBX) has entered into a definitive merger agreement with Caldera Therapeutics, a private biotech, via a reverse-merger structure. Synlogic shareholders will receive shares in a new public parent company (Sonic Holdco) and are expected to own only ~2.3% of the combined entity, while Caldera's pre-merger equity holders will own ~62.8%. The transaction is accompanied by a $278 million concurrent PIPE financing from new investors, who will own ~34.9% of the combined company. This represents a de facto acquisition of Synlogic by Caldera, with Synlogic's existing shareholders receiving a minimal stake, effectively a change of control that values Synlogic at $18 million. The deal is structured as a tax-free reorganization and requires Synlogic stockholder approval, with ~50.9% of shares already committed via support agreements. For SYBX holders, this is a bearish event as they are being diluted to a ~2.3% stake in a new entity controlled by Caldera's backers, with the stock likely to be delisted from the OTC Pink Sheets upon closing.

Key Financial Metrics

Key Facts

• Synlogic will merge into a wholly owned subsidiary of a new parent company (Sonic Holdco), with Synlogic shareholders receiving shares in the new parent.
• Pre-merger Synlogic equity holders are expected to own approximately 2.3% of the combined company on a fully diluted basis.
• Pre-merger Caldera equity holders (excluding PIPE investors) are expected to own approximately 62.8% of the combined company.
• A concurrent PIPE financing of $278 million will be raised by Caldera, with those investors expected to own approximately 34.9% of the combined company.
• The implied valuation for Synlogic in the transaction is $18.0 million, assuming $6.0 million in net cash at closing.
• Caldera's implied valuation is $500.0 million.
• Stockholders holding ~50.9% of Synlogic's outstanding stock have entered into support agreements to vote in favor of the merger.
• The merger agreement includes a termination fee of $1.0 million payable by Synlogic to Caldera under certain circumstances, and a $5.0 million fee payable by Caldera to Synlogic under other circumstances.
• Synlogic's existing warrants were amended to reduce the exercise price to $0.70 per share and remove the cash redemption right upon a fundamental transaction.
• The combined company's shares of Parent Common Stock are expected to be listed on Nasdaq.

Financial Impact

Synlogic shareholders are being diluted to a ~2.3% stake in the combined entity, with an implied valuation of $18 million for Synlogic. The concurrent PIPE of $278 million will be used to fund the combined company's operations, primarily Caldera's pipeline.

Risk Factors

• The merger may not close if Synlogic stockholders do not approve it, though ~50.9% of shares are already committed to vote in favor.
• The transaction is subject to regulatory approvals and Nasdaq listing approval for the new parent company's shares.
• Synlogic's stock is currently quoted on the OTC Pink market and will be delisted upon closing, leaving no public market for legacy SYBX shares.

Market Snapshot

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

US Market Status